Mira Pharmaceuticals receives Nasdaq delisting notice for bid price below $1

MIRA PHARMACEUTICALS, INC.

Received Nasdaq letter on July 27, 2026 for failing minimum bid price of $1 per share.
Has 180 calendar days, until January 25, 2027, to regain compliance.
To comply, closing bid must be at least $1 for ten consecutive business days.
May seek an additional 180-day period if it meets other listing standards.
Stock continues trading on Nasdaq under MIRA; no immediate delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.